Plants have been developed as an alternative platform for the production of biopharmaceutical proteins, culminating recently with the FDA approval of the first plant-derived recombinant pharmaceutical enzyme for human use (ELELYSOÔ by Protalix Biotherapeutics). Among the many different plant-based technologies that have been proposed, transient expression mediated by Agrobacterium tumefaciens has proven to be particularly suitable for the rapid production of vaccines in response to emerging pandemics. However, one potential drawback of transient expression in whole plants is the large variation in recombinant protein expression levels among different leaves, which introduces a level of uncertainty in process design that can increase the reg...
Addressing new challenges in global health and biosecurity requires responsive and accessible platfo...
The production of recombinant pharmaceutical proteins in plants is entering a new phase with the rec...
The production of therapeutic and industrial recombinant proteins in plants has advantages over esta...
The transient expression of recombinant biopharmaceutical proteins in plants can suffer inter-batch ...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants offer an alternative to microbial fermentation and animal cell cultures for the production of...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants are now gaining widespread acceptance as a general platform for the large-scale production of...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants provide an inexpensive and convenient system for the large-scale production of valuable recom...
Molecular farming in plants can be achieved by stable or transient expression of a recombinant prote...
Using transgenic plants for the production of high-value recombinant proteins for industrial and cli...
Addressing new challenges in global health and biosecurity requires responsive and accessible platfo...
The production of recombinant pharmaceutical proteins in plants is entering a new phase with the rec...
The production of therapeutic and industrial recombinant proteins in plants has advantages over esta...
The transient expression of recombinant biopharmaceutical proteins in plants can suffer inter-batch ...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants offer an alternative to microbial fermentation and animal cell cultures for the production of...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants are now gaining widespread acceptance as a general platform for the large-scale production of...
Over the last three decades, the expression of recombinant proteins in plants and plant cells has be...
Plants provide an inexpensive and convenient system for the large-scale production of valuable recom...
Molecular farming in plants can be achieved by stable or transient expression of a recombinant prote...
Using transgenic plants for the production of high-value recombinant proteins for industrial and cli...
Addressing new challenges in global health and biosecurity requires responsive and accessible platfo...
The production of recombinant pharmaceutical proteins in plants is entering a new phase with the rec...
The production of therapeutic and industrial recombinant proteins in plants has advantages over esta...